knowledge -WSS

knowledge

author：knowledge 2025-09-08 04:01:43 - browse：83

Rising drug prices —Medicare coverage from STAT — Medicare on Friday released new details about how its new drug price negotiation program will work, just two months before it’s set to start. APStock

WASHINGTON — Medicare on Friday released new details about how its new drug price negotiation program will work, just two months before it’s set to start.

Medicare released an initial outline of how the program will work in March. Some parts, including the outline of how drugs would be selected for the negotiation process, were immediately final. The agency asked drug companies, patients, and other affected parties to weigh in on other parts about how the process would proceed, what factors would be considered, and how drugmakers would be held accountable.

Newsletters

Sign up for D.C. Diagnosis

An insider's guide to the politics and policies of health care

Please enter a valid email address. Privacy Policy

The negotiation process was created last August in Democrats’ drug pricing reform law, and Medicare is supposed to select the first 10 drugs that will be subject to negotiation by Sept. 1.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.

knowledge

WSS

Eli Lilly reports tirzepatide MASH success during Q4 earnings

Why don't Americans have at

Report cites 'urgent' need to recruit more diverse clinical trial participants

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

Here’s what’s in the FDA plan to include pregnant women in clinical trials

Websites selling Wegovy, Zepbound ingredients targeted by FDA

knowledge

knowledge

Sign up for D.C. Diagnosis

leisure time

Medical leaders decry Supreme Court decision on affirmative action

To avoid data mishandling cases, universities eye AI and other tools

Jerome Adams on the need for new antivirals for Covid

What should King Charles tell the public about his cancer?

What does generative AI mean for health care? We asked experts

Gilead might be held responsible for not developing a drug

Novavax promises a turnaround & Lilly roils the obesity market

Senators start work on Medicare physician payment reform

How one medical school became remarkably diverse

Readout Newsletter: Amylyx, Aurinia, and IQVIA

explore

'Revelatory' study finds a smoking impact that remains after quitting

Why Eli Lilly’s earnings didn’t quite live up to the hype

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

Latigo launches with $135 million for Vertex

'Revelatory' study finds a smoking impact that remains after quitting

hotspot

knowledge

entertainment

focus